Journal of the Society of Chemical Industry.

Includes list of members, 1882-1902, proceedings of the annual meetings and various supplements.

Textile chemistry.

"Lithoprinted ... [by] Edwards Brothers, inc., Ann Arbor, Michigan."

Eighth International congress of applied chemistry, Washington and New York, September 4 to 13, 1912.

"Members": v. 28, p. 365-463.

Seventh International Congress of Applied Chemistry, London, May 27th to June 2d, 1909.

Edited by Sir William Ramsay, William Macnab, and others.

Treatise on analytical chemistry.

Publisher varies: 1961-68, Interscience Publishers; 1971- Wiley-Interscience and Wiley (an Interscience publication).

The chemical formulary : a condensed collection of valuable, timely, practical formulae for making thousands of products in all fields of industry /

Mode of access: Internet.

A laboratory guide in dairy industry for agricultural and vocational schools,

"References" at end of each "Exercise."

Electrochemical and metallurgical industry.

Title from cover.

Farm products in industry,

"Based on a survey which the author made during the winter of 1927-28 for Hon. W.M. Jardine, United States secretary of agriculture, of research data in Washington and elsewhere which have a bearing on the industrial utilization of farm products."--Pref.

Reports of the Progress of Applied Chemistry

Mode of access: Internet.

Academic Experience and Personal Abilities in Analytical Chemistry Education

Report published in the Proceedings of the National Conference on "Education and Research in the Information Society", Plovdiv, May, 2016

Nanotechnology in the food industry I: applications

Nanotechnology is a multidisciplinary science that is having a boom today, providing new products with attractive physicochemical properties for many applications. In agri/feed/food sector, nanotechnology offers great opportunities for obtaining products and innovative applications for agriculture and livestock, water treatment and the production, processing, storage and packaging of food. To this end, a wide variety of nanomaterials, ranging from metals and inorganic metal oxides to organic nanomaterials carrying bioactive ingredients are applied. This review shows an overview of current and future applications of nanotechnology in the food industry. Food additives and materials in contact with food are now the main applications, while it is expected that in the future are in the field of nano-encapsulated and nanocomposites in applications as novel foods, additives, biocides, pesticides and materials food contact.

Usability of clay mixed red mud in Hungarian building material production industry

The naturally occurring radionuclide (²²⁶Ra,²³²Th and⁴⁰K) content of building Materials (NORM) contributes to the total radiation dose experienced by humans. In this survey 27 clay and 68 red mud samples were surveyed with gamma spectrometry and screened according to European Basic Safety Standards (BSS) I-index. It was found that average I-index of clays was 0.6 (0.4–0.8) less than the I-index of 1, which makes them suitable for building material production. The average I-index of red mud 2.3 (1.3–3.0). The maximal mixing ratio of red mud was calculated, varied between 12 and 39 %, with 23 % average.

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

Peptides are receiving increasing interest as clinical therapeutics. These highly tunable molecules can be tailored to biocompatibility and biodegradability with simultaneously selective and potent therapeutic effects. Despite challenges regarding up-scaling and licensing of peptide products, their vast clinical potential is reflected in the 60 plus peptide-based therapeutics already on the market, and the further 500 derivatives currently in developmental stages. Peptides are proving effective for a multitude of disease states including: type 2 diabetes (controlled using the licensed glucagon-like peptide-1 receptor liraglutide); irritable bowel syndrome managed with linaclotide (currently at approval stages); acromegaly (treated with octapeptide somostatin analogues lanreotide and octreotide); selective or broad spectrum microbicidal agents such as the Gram-positive selective PTP-7 and antifungal heliomicin; anticancer agents including goserelin used as either adjuvant or for prostate and breast cancer,and the first marketed peptide derived vaccine against prostate cancer, sipuleucel-T. Research is also focusing on improving the biostability of peptides. This is achieved through a number of mechanisms ranging from replacement of naturally occurring L-amino acid enantiomers with D-amino acid forms, lipidation, peptidomimetics, N-methylation, cyclization and exploitation of carrier systems. The development of self-assembling peptides are paving the way for sustained release peptide formulations and already two such licensed examples exist, lanreotide and octreotide. The versatility and tunability of peptide-based products is resulting in increased translation of peptide therapies, however significant challenges remain with regard to their wider implementation. This review highlights some of the notable peptide therapeutics discovered to date and the difficulties encountered by the pharmaceutica lindustry in translating these molecules to the clinical setting for patient benefit, providing some possible solutions to the most challenging barriers.